Insider Transactions in Q1 2025 at Poseida Therapeutics, Inc. (PSTX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 08
2025
|
Malin Life Sciences Holdings LTD > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
11,835,673
-100.0%
|
-
|
|
Jan 08
2025
|
Marcea Bland Lloyd |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
68,950
-100.0%
|
-
|
|
Jan 08
2025
|
John P. Schmid |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
58,950
-100.0%
|
-
|
|
Jan 08
2025
|
Luke Corning |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
58,950
-100.0%
|
-
|
|
Jan 08
2025
|
Rafael Amado |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
58,950
-100.0%
|
-
|
|
Jan 08
2025
|
Harry J Leonhardt GC & Chief Compliance Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
223,640
-100.0%
|
-
|
|
Jan 08
2025
|
Syed Ali Aamir Rizvi Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
185,000
-100.0%
|
-
|
|
Jan 08
2025
|
Johanna Mylet Chief Financial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
254,852
-100.0%
|
-
|
|
Jan 08
2025
|
Charles M Baum |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
78,600
-100.0%
|
-
|
|
Jan 08
2025
|
Cynthia Collins |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
58,950
-100.0%
|
-
|
|
Jan 08
2025
|
Kristin Yarema President and CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
615,836
-100.0%
|
-
|
|
Jan 08
2025
|
Mark J Gergen President and CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
636,726
-100.0%
|
-
|
|
Jan 02
2025
|
Mark J Gergen President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,313
-3.56%
|
$209,817
$9.6 P/Share
|